Baker Bros. Advisors LP Syros Pharmaceuticals, Inc. Transaction History

Baker Bros. Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.08 - $5.66 $267,227 - $370,713	-65,497 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $3.13 Million - $4.67 Million	-624,670 Reduced 90.51%	65,497 $357,000
Q4 2019 Feb 14, 2020	SELL	$4.52 - $10.1 $1.29 Million - $2.88 Million	-284,668 Reduced 29.2%	690,167 $4.77 Million
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $2.2 Million - $3.9 Million	400,000 Added 69.59%	974,835 $9.03 Million
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $7.77 Million - $13.7 Million	574,835	574,835 $8.46 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $104M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.